Zobrazeno 1 - 10
of 347
pro vyhledávání: '"M, Blumenfeld"'
Publikováno v:
Neurology and Therapy, Vol 13, Iss 6, Pp 1535-1540 (2024)
Externí odkaz:
https://doaj.org/article/57a0877348da4184b7ff7d0b17021a4c
Autor:
Andrew M. Blumenfeld, Laszlo Mechtler, Lisa Cook, Christopher Rhyne, Brian Jenkins, Olivia Hughes, Brett Dabruzzo, Aubrey Manack Adams, Merle Diamond
Publikováno v:
Pain and Therapy, Vol 13, Iss 6, Pp 1571-1587 (2024)
Abstract Introduction Combination use of atogepant and onabotulinumtoxinA has the potential to be more effective than either alone for the preventive treatment of chronic migraine (CM) due to their complementary mechanisms of action. This analysis co
Externí odkaz:
https://doaj.org/article/9bb21333a6b9477695cc5d48969da9f6
Autor:
Andrew M. Blumenfeld, Richard B. Lipton, Stephen Silberstein, Stewart J. Tepper, Larry Charleston, Stephen Landy, Deena E. Kuruvilla, Aubrey Manack Adams
Publikováno v:
Neurology and Therapy, Vol 12, Iss 5, Pp 1533-1551 (2023)
Abstract Migraine is a neurologic disease with a complex pathophysiology that can be controlled with current treatment options but not cured. Therefore, treatment expectations are highly variable. The concept of migraine freedom was recently introduc
Externí odkaz:
https://doaj.org/article/bb3f6e1700ef433e92ce463429385b39
Autor:
Andrew M. Blumenfeld, James P. Boyd
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Objective To assess the nocioceptive input of habitual nocturnal jaw clenching that acts as a contributing factor in migraine pathogenesis. Background Habitual nocturnal jaw clenching has been implicated as a trigger, particularly in those w
Externí odkaz:
https://doaj.org/article/af287a66c88145f48bd811231cd2fdd6
Autor:
David B. Clemow, Kirk W. Johnson, Helen M. Hochstetler, Michael H. Ossipov, Ann M. Hake, Andrew M. Blumenfeld
Publikováno v:
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-13 (2020)
Abstract Migraine is a leading cause of disability worldwide, but it is still underdiagnosed and undertreated. Research on the pathophysiology of this neurological disease led to the discovery that calcitonin gene-related peptide (CGRP) is a key neur
Externí odkaz:
https://doaj.org/article/2862c682cbcd488db55c7f0c23bb485b
Autor:
William B. Young, J. Ivan Lopez, John F. Rothrock, Amelia Orejudos, Aubrey Manack Adams, Richard B. Lipton, Andrew M. Blumenfeld
Publikováno v:
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background OnabotulinumtoxinA is effective in preventing chronic migraine (CM); however, the benefit of onabotulinumtoxinA in patients with CM with daily headache is unknown because these patients are typically excluded from clinical trials.
Externí odkaz:
https://doaj.org/article/fe8740504e1e4f8da398ab5cc3ea9155
Autor:
William B. Young, J. Ivan Lopez, John F. Rothrock, Amelia Orejudos, Aubrey Manack Adams, Richard B. Lipton, Andrew M. Blumenfeld
Publikováno v:
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background OnabotulinumtoxinA is effective in treating chronic migraine (CM), but there are limited data assessing how allodynia affects preventive treatment responses. This subanalysis of the 108-week, multicenter, open-label COMPEL Study a
Externí odkaz:
https://doaj.org/article/34919c94b35746dba55267f019599f2b
Autor:
Stewart J. Tepper, Liron Rabany, Robert P. Cowan, Timothy R. Smith, Brian M. Grosberg, Bradley D. Torphy, Dagan Harris, Maya Vizel, Alon Ironi, Alit Stark‐Inbar, Andrew M. Blumenfeld
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:377-389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31e26cb152c8c96c11b6c6dff955d2aa
https://doi.org/10.1111/head.14469
https://doi.org/10.1111/head.14469
Autor:
Andrew M, Blumenfeld, Ramesh, Boinpally, Rosa, De Abreu Ferreira, Joel M, Trugman, Brett, Dabruzzo, Jessica, Ailani, Richard B, Lipton
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:322-332
To evaluate potential drug-drug interactions of ubrogepant and atogepant.Ubrogepant and atogepant, calcitonin gene-related peptide (CGRP) receptor antagonists, are recently approved drugs for acute and preventive treatment of migraine, respectively.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549e1809f1125ec77357581c11ef064c
https://doi.org/10.1111/head.14433
https://doi.org/10.1111/head.14433
Autor:
Messoud Ashina, Stewart J. Tepper, Uwe Reuter, Andrew M. Blumenfeld, Susan Hutchinson, Jing Xia, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M. Trugman
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:79-88
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00b6edef4b5f5bb502d645c796348414
https://doi.org/10.1111/head.14439
https://doi.org/10.1111/head.14439